With the ABTA, You Are Not Alone
Thanks to the work of the American Brain Tumor Association, those impacted by brain tumors—both patients and those who love and care for them—know that they are not alone. Our licensed Care Consultants provide answers to those facing the fear and uncertainty that comes with a brain tumor diagnosis, while ABTA-funded researchers pursue new breakthroughs in the brain tumor field. And now, even a donation to the ABTA is part of something larger. Support the 2011 Annual Appeal and learn how your gift will go twice as far in helping to ensure that hose touched by a brain tumor diagnosis are not alone.
Fall-Winter 2011 Headlines Available for Download
The new issue of Headlines highlights ABTA-funded research that is shaping exciting developments in the treatment of brain tumors. You will also learn about our new Support Group Leader Training Program, as well as recent ABTA collaborations and upcoming events. Download the 2011 Fall-Winter Headlines.
Introducing the Breakthrough for Brain Tumors 5K Event
In 2012, the ABTA 5K is expanding beyond Chicago to New York City. Join us at Breakthrough for Brain Tumors Chicago in May or Breakthrough for Brain Tumors New York in November. For more information visit our new website at www.breakthroughforbraintumors.org or email firstname.lastname@example.org.
Team Breakthrough: Helping the ABTA to Move Forward
The American Brain Tumor Association is also expanding its endurance running program, Team Breakthrough, in 2012. Team Breakthrough trains with a purpose – to help improve, extend and ultimately save the lives of the 600,000 people living with brain tumors in the U.S. We are currently recruiting for the Bank of America Chicago Marathon. Visit www.abtateambreakthrough.org or contact Alisha Kassam at email@example.com or (773) 577-8763 for more information and a full list of Team Breakthrough opportunities around the country.
Ten Tips for the Holiday Season
It's the holiday season, time for shopping, decorating, cooking, company… and stress. Just thinking about the holidays may leave you feeling overwhelmed. To help ease you into the holiday season, we’ve compiled a few helpful strategies to remember while you’re planning. Click here to read our holiday tips.
Cancer, the Flu and You
Living with cancer increases your risk for complications from influenza ("flu"). If you have cancer now or have had cancer in the past, you are at higher risk for complications from the seasonal flu or influenza, so it is important to be prepared for the cold and flu season. Click here for information on preparing for this year’s flu season.
2011 Society of NeuroOncology Annual Meeting
The American Brain Tumor Association research and patient services departments joined over 1400 neuro-oncology health care professionals and scientists at The Society for NeuroOncology (SNO) Annual Meeting was held in Anaheim, CA from November 17 through November 20, 2011. The organization, whose founding was facilitated by support from the American Brain Tumor Association, blends professionals from different disciplines into a forum for sharing brain tumor research and treatment practices.
|Elizabeth Wilson, President and CEO of the American Brain Tumor Association (left), and Justin Lathia, PhD.
One recurrent theme of the meeting was the evolving knowledge of the molecular difference in tumors and its application to individualized therapies. While much of the current research now occurs in the clinical trial setting, this information could ultimately redefine patient care and treatment. Being able to share this information in such a forum allows health care professionals to know what treatments are in the pipeline, and the American Brain Tumor Association is already working on using the information from this year’s meeting to help patients and families now and to plan for the future.
New Precision Tool for Brain Surgeons
Removing brain tumors is one of the most difficult surgeries in medicine. Researchers at the Institute for Inorganic and Analytical Chemistry at Justus-Liebig-University have developed a new tool out of two existing ones to improve the precision and accuracy of brain tumor removal. Click here to read this article.
Agenus Vaccine for Brain Cancer Highlighted at Current State of the Art Session at the Annual Society for Neuro-Oncology (SNO) Meeting
Dr. Michael Sughrue, incoming Director of the Comprehensive Brain Tumor Center, University of Oklahoma, will give a presentation on Agenus’ Prophage Series G-200 vaccine for glioma. This series of vaccines are patient-specific cancer vaccine candidates that are designed to target only cancerous cells. Click here to read this article.
Celldex Therapeutics Reports Positive Mature Survival Data from Rindopepimut Phase 2 Brain Cancer Study at SNO 2011
Celldex Therapeutics announced the mature overall survival (OS) data for ACT III, a clinical trial of rindopepimut in patients with newly diagnosed EGFRvIII-positive Glioblastoma. The data showed a final median OS of 24.6 months from diagnosis. This is significantly better than the 15.2 months for a historical cohort of patients selected to match ACT III eligibility. Click here to read this article.
Founded in 1973, the American Brain Tumor Association was the first national nonprofit organization dedicated solely to brain tumors. For nearly 40 years, the Chicago-based ABTA has provided critical funding to researchers working toward breakthroughs in brain tumor diagnosis, treatment and care, and is the only national organization providing comprehensive resources and serving the complex supportive care needs of brain tumor patients and caregivers.
Make a donation to the American Brain Tumor Association.
This information is provided by the American Brain Tumor Association, 8550 W. Bryn Mawr Ave., Suite 550, Chicago, Illinois, 60631. For more information on the American Brain Tumor Association, call toll-free: 1.800.886.ABTA (2282), write firstname.lastname@example.org, or visit www.abta.org.
Update Email Preferences | Forward to a Friend | Unsubscribe
©2011 American Brain Tumor Association
Last Call for Holiday Cards
It's not too late to purchase your holiday cards from the American Brain Tumor Association--we'll receive 50% of the profits from the cards you buy and 100% of any donation* you make.
Prices start at $29 for a box of 25. Ordering deadline for personalized cards is December 9, 2011 and non-personalized cards is December 12, 2011.
View and order cards online by clicking here or call 1.888.487.5567 for a brochure. Contact Erica Jones at email@example.com or 773-577-8750 with any questions.
*All donations are tax deductible.
SAVE THE DATES
December 10, 2011
The Christmas Schooner
December 10, 2011
A Holiday Fundraiser
December 16, 2011
The Grinch Who Gave Back Christmas
Discover Community Support with ABTA Connections
Our Connections Online Support Community links patients, families, friends, caregivers and healthcare professionals with each other for support and inspiration. The online community was created to provide a safe place to visit, join and interact with over 400 members of the brain tumor community nationally and around the world.
Find a Clinical Trial Through TrialConnect™
The American Brain Tumor Association offers a service that links brain tumor patients with appropriate clinical trials based on tumor type and treatment history. TrialConnect™, a free and confidential service administered by EmergingMed, is offered in English and Spanish. Read more.
Trained healthcare professionals who provide brain tumor information, support and education for patients, families and healthcare professionals are available via email at firstname.lastname@example.org or by calling our toll-free CareLine at 1-800-886-ABTA (2282).